KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Gross Margin (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Gross Margin for 6 consecutive years, with 9.15% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 1982.0% year-over-year to 9.15%, compared with a TTM value of 17.09% through Dec 2025, down 951.0%, and an annual FY2025 reading of 17.09%, down 951.0% over the prior year.
  • Gross Margin was 9.15% for Q4 2025 at Clover Health Investments, down from 14.73% in the prior quarter.
  • Across five years, Gross Margin topped out at 384.85% in Q4 2022 and bottomed at 219.84% in Q2 2022.
  • Average Gross Margin over 5 years is 17.15%, with a median of 14.77% recorded in 2023.
  • The sharpest move saw Gross Margin plummeted -21425bps in 2021, then surged 38634bps in 2022.
  • Year by year, Gross Margin stood at 1.49% in 2021, then skyrocketed by 25931bps to 384.85% in 2022, then tumbled by -96bps to 14.57% in 2023, then surged by 99bps to 28.97% in 2024, then tumbled by -68bps to 9.15% in 2025.
  • Business Quant data shows Gross Margin for CLOV at 9.15% in Q4 2025, 14.73% in Q3 2025, and 21.75% in Q2 2025.